TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10932688
log Bayes Factor = 0.207175
Chromosome 2   position 217,863,481  (GRCh37) Explore rs10932688 on Ensembl!
Variant rs10932688 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
C18 Malignant neoplasm of colon
0.307 0.693 0.000
C18.0 Caecum
0.303 0.697 0.000
C18.9 Colon, unspecified
0.300 0.700 0.000
C18.5 Splenic flexure
0.299 0.701 0.000
C18.4 Transverse colon
0.290 0.710 0.000
C18.2 Ascending colon
0.281 0.719 0.000
C18.8 Overlapping lesion of colon
0.251 0.749 0.000
C18.3 Hepatic flexure
0.225 0.775 0.000
D12.3 Transverse colon
0.140 0.860 0.000
C18.1 Appendix
0.133 0.866 0.000
C18.7 Sigmoid colon
0.102 0.898 0.000
D12.4 Descending colon
0.097 0.903 0.000
C18.6 Descending colon
0.097 0.903 0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal
0.091 0.909 0.000
D12.2 Ascending colon
0.082 0.918 0.000
D12.5 Sigmoid colon
0.070 0.930 0.000
D12.6 Colon, unspecified
0.062 0.938 0.000
D12.1 Appendix
0.057 0.943 0.000
D12.9 Anus and anal canal
0.055 0.945 0.000
H34.2 Other retinal artery occlusions
0.000 0.955 0.045
Z30.1 Insertion of (intra-uterine) contraceptive device
0.030 0.970 0.000
D12.7 Rectosigmoid junction
0.026 0.973 0.000
Z30 Contraceptive management
0.027 0.973 0.000
H34 Retinal vascular occlusions
0.000 0.974 0.026
Z30.8 Other contraceptive management
0.025 0.975 0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device
0.023 0.977 0.000
Z30.3 Menstrual extraction
0.022 0.978 0.000
Z30.2 Sterilisation
0.022 0.978 0.000
H34.8 Other retinal vascular occlusions
0.000 0.979 0.021
D12.0 Caecum
0.020 0.980 0.000
Z30.9 Contraceptive management, unspecified
0.019 0.981 0.000
Z30.4 Surveillance of contraceptive drugs
0.019 0.981 0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures
0.019 0.981 0.000
H34.9 Retinal vascular occlusion, unspecified
0.000 0.981 0.018
H34.0 Transient retinal artery occlusion
0.000 0.981 0.018
H34.1 Central retinal artery occlusion
0.000 0.983 0.017
G40.3 Generalised idiopathic epilepsy and epileptic syndromes
0.015 0.985 0.000
Z30.0 General counselling and advice on contraception
0.014 0.986 0.000
Y45.1 Salicylates
0.014 0.986 0.000
Y52 Agents primarily affecting the cardiovascular system
0.014 0.986 0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)
0.014 0.986 0.000
G40 Epilepsy
0.014 0.986 0.000
C15-C26 Malignant neoplasms of digestive organs
0.014 0.986 0.000
G40.9 Epilepsy, unspecified
0.014 0.986 0.000
K14.8 Other diseases of tongue
0.000 0.987 0.013
Y52.7 Peripheral vasodilators
0.013 0.987 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.013 0.987 0.000
Z89.5 Acquired absence of leg at or below knee
0.000 0.988 0.012
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.012 0.988 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.012 0.988 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.012 0.988 0.000
Y52.1 Calcium-channel blockers
0.012 0.988 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.012 0.988 0.000
C22.9 Liver, unspecified
0.012 0.988 0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
0.012 0.988 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.012 0.988 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.012 0.988 0.000
Y45.2 Propionic acid derivatives
0.011 0.988 0.000
C16 Malignant neoplasm of stomach
0.011 0.989 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.011 0.989 0.000
Y42.5 Other oestrogens and progestogens
0.011 0.989 0.000
M77.47 Metatarsalgia-Ankle/Foot
0.000 0.989 0.011
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.011 0.989 0.000
Y44 Agents primarily affecting blood constituents
0.011 0.989 0.000
G40.4 Other generalised epilepsy and epileptic syndromes
0.011 0.989 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.011 0.989 0.000
Y40 Systemic antibiotics
0.011 0.989 0.000
C24.1 Ampulla of Vater
0.011 0.989 0.000
Y45.8 Other analgesics and antipyretics
0.010 0.989 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.010 0.990 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.010 0.990 0.000
C16.5 Lesser curvature of stomach, unspecified
0.010 0.990 0.000
K50.0 Crohn's disease of small intestine
0.000 0.990 0.010
G40.7 Petit mal, unspecified, without grand mal seizures
0.010 0.990 0.000
Y40.3 Macrolides
0.010 0.990 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.010 0.990 0.000
G40.5 Special epileptic syndromes
0.010 0.990 0.000
C22.1 Intrahepatic bile duct carcinoma
0.010 0.990 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.010 0.990 0.000
C16.2 Body of stomach
0.010 0.990 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.010 0.990 0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.010 0.990 0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset
0.009 0.990 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.010 0.990 0.000
Y44.6 Natural blood and blood products
0.009 0.990 0.000
N81.5 Vaginal enterocele
0.010 0.990 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.009 0.991 0.000
Y40.8 Other systemic antibiotics
0.009 0.991 0.000
Y45.4 Antirheumatics
0.009 0.991 0.000
Y42.9 Other and unspecified hormone antagonists
0.009 0.991 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.009 0.991 0.000
D12.8 Rectum
0.009 0.991 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.009 0.991 0.000
C24.9 Biliary tract, unspecified
0.009 0.991 0.000
C22.7 Other specified carcinomas of liver
0.009 0.991 0.000
C22.4 Other sarcomas of liver
0.009 0.991 0.000
C22.3 Angiosarcoma of liver
0.009 0.991 0.000
C22.2 Hepatoblastoma
0.009 0.991 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.009 0.991 0.000
C16.1 Fundus of stomach
0.009 0.991 0.000
C17 Malignant neoplasm of small intestine
0.009 0.991 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.009 0.991 0.000
R59.9 Enlarged lymph nodes, unspecified
0.009 0.991 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.009 0.991 0.000
Y58 Bacterial vaccines
0.009 0.991 0.000
Y40.6 Rifamycins
0.009 0.991 0.000
C24.8 Overlapping lesion of biliary tract
0.009 0.991 0.000
Y59 Other and unspecified vaccines and biological substances
0.009 0.991 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.009 0.991 0.000
C16.9 Stomach, unspecified
0.009 0.991 0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.009 0.991 0.000
Y40.4 Tetracyclines
0.009 0.991 0.000
Y45.5 4-Aminophenol derivatives
0.008 0.991 0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.008 0.991 0.000
C24.0 Extrahepatic bile duct
0.008 0.991 0.000
Y42.1 Thyroid hormones and substitutes
0.008 0.992 0.000
C16.8 Overlapping lesion of stomach
0.008 0.992 0.000
Y54.8 Agents affecting uric acid metabolism
0.008 0.992 0.000
C26.9 Ill-defined sites within the digestive system
0.008 0.992 0.000
C16.6 Greater curvature of stomach, unspecified
0.008 0.992 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.008 0.992 0.000
Y42.4 Oral contraceptives
0.008 0.992 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.008 0.992 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.008 0.992 0.000
Y42.7 Androgens and anabolic congeners
0.008 0.992 0.000
Y42.2 Antithyroid drugs
0.008 0.992 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.008 0.992 0.000
Y44.7 Plasma substitutes
0.008 0.992 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.008 0.992 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.008 0.992 0.000
C26.8 Overlapping lesion of digestive system
0.008 0.992 0.000
C26.1 Spleen
0.008 0.992 0.000
Y40.7 Antifungal antibiotics, systemically used
0.008 0.992 0.000
Y40.2 Chloramphenicol group
0.008 0.992 0.000
Y40.5 Aminoglycosides
0.008 0.992 0.000
G40.8 Other epilepsy
0.008 0.992 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.008 0.992 0.000
C26.0 Intestinal tract, part unspecified
0.008 0.992 0.000
C21 Malignant neoplasm of anus and anal canal
0.008 0.992 0.000
C17.2 Ileum
0.008 0.992 0.000
Y44.2 Anticoagulants
0.008 0.992 0.000
Y54.5 Other diuretics
0.007 0.992 0.000
C16.4 Pylorus
0.007 0.992 0.000
Y44.5 Thrombolytic drugs
0.007 0.992 0.000
L40.9 Psoriasis, unspecified
0.007 0.993 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.007 0.993 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.007 0.993 0.000
Y41.5 Antiviral drugs
0.007 0.993 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.007 0.993 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.007 0.993 0.000
Y54.7 Agents affecting calcification
0.007 0.993 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.007 0.993 0.000
Y57 Other and unspecified drugs and medicaments
0.007 0.993 0.000
Y54.9 Mineral salts, not elsewhere classified
0.007 0.993 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.007 0.993 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.007 0.993 0.000
Y54.0 Mineralocorticoids
0.007 0.993 0.000
Y56.9 Topical agent, unspecified
0.007 0.993 0.000
Y56.8 Other topical agents
0.007 0.993 0.000
Y56.7 Dental drugs, topically applied
0.007 0.993 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.007 0.993 0.000
Y56.5 Ophthalmological drugs and preparations
0.007 0.993 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.007 0.993 0.000
Y56.3 Emollients, demulcents and protectants
0.007 0.993 0.000
Y56.2 Local astringents and local detergents
0.007 0.993 0.000
Y56.1 Antipruritics
0.007 0.993 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.007 0.993 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.007 0.993 0.000
Y54.3 Benzothiadiazine derivatives
0.007 0.993 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.007 0.993 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.007 0.993 0.000
Y53.7 Emetics
0.007 0.993 0.000
Y53.6 Antidiarrhoeal drugs
0.007 0.993 0.000
Y53.5 Digestants
0.007 0.993 0.000
Y53.3 Saline and osmotic laxatives
0.007 0.993 0.000
Y53.2 Stimulant laxatives
0.007 0.993 0.000
Y53.0 Histamine H2-receptor antagonists
0.007 0.993 0.000
Y45.0 Opioids and related analgesics
0.007 0.993 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.007 0.993 0.000
Y55.5 Anticommon cold drugs
0.007 0.993 0.000
Y55.4 Expectorants
0.007 0.993 0.000
Y55.3 Antitussives
0.007 0.993 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.007 0.993 0.000
Y55.0 Oxytocic drugs
0.007 0.993 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.007 0.993 0.000
C16.3 Pyloric antrum
0.007 0.993 0.000
C17.8 Overlapping lesion of small intestine
0.007 0.993 0.000
C17.3 Meckel's diverticulum
0.007 0.993 0.000
Y50.9 Central nervous system stimulant, unspecified
0.007 0.993 0.000
Y50.8 Other central nervous system stimulants
0.007 0.993 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.007 0.993 0.000
Y50.1 Opioid receptor antagonists
0.007 0.993 0.000
Y50.0 Analeptics
0.007 0.993 0.000
H30-H36 Disorders of choroid and retina
0.000 0.993 0.007
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
Y53.4 Other laxatives
0.007 0.993 0.000
Y48 Anaesthetics and therapeutic gases
0.007 0.993 0.000
Z89 Acquired absence of limb
0.000 0.993 0.007
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.007 0.993 0.000
Y41.4 Anthelminthics
0.007 0.993 0.000
Y41.3 Other antiprotozoal drugs
0.007 0.993 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.007 0.993 0.000
Y41.1 Antimycobacterial drugs
0.007 0.993 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.007 0.993 0.000
Y58.9 Other and unspecified bacterial vaccines
0.006 0.993 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.006 0.993 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.006 0.993 0.000
Y58.5 Diphtheria vaccine
0.006 0.993 0.000
Y58.4 Tetanus vaccine
0.006 0.993 0.000
Y58.3 Plague vaccine
0.006 0.993 0.000
Y58.2 Cholera vaccine
0.006 0.993 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.006 0.993 0.000
Y58.0 BCG vaccine
0.006 0.993 0.000
C17.0 Duodenum
0.006 0.993 0.000
N43.3 Hydrocele, unspecified
0.007 0.993 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.006 0.993 0.000
H33.0 Retinal detachment with retinal break
0.000 0.993 0.007
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.006 0.993 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.006 0.993 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.006 0.993 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.006 0.993 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.006 0.993 0.000
Y51.0 Anticholinesterase agents
0.006 0.993 0.000
Y57.5 X-ray contrast media
0.006 0.993 0.000
Y59.9 Vaccine or biological substance, unspecified
0.006 0.993 0.000
Y59.8 Other specified vaccines and biological substances
0.006 0.993 0.000
Y59.2 Protozoal vaccines
0.006 0.993 0.000
Y59.1 Rickettsial vaccines
0.006 0.993 0.000
Y59.0 Viral vaccines
0.006 0.993 0.000
C23 Malignant neoplasm of gallbladder
0.006 0.993 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.006 0.994 0.000
Y46.7 Anti-Parkinsonism drugs
0.006 0.994 0.000
C16.0 Cardia
0.006 0.994 0.000
C22.0 Liver cell carcinoma
0.006 0.994 0.000
Z89.6 Acquired absence of leg above knee
0.000 0.994 0.006
C15 Malignant neoplasm of oesophagus
0.006 0.994 0.000
H33 Retinal detachments and breaks
0.000 0.994 0.006
K14 Diseases of tongue
0.000 0.994 0.006
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.006 0.994 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.006 0.994 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.006 0.994 0.000
Y47.4 Bromine compounds
0.006 0.994 0.000
Y47.3 Paraldehyde
0.006 0.994 0.000
Y47.2 Chloral derivatives
0.006 0.994 0.000
Y47.0 Barbiturates, not elsewhere classified
0.006 0.994 0.000
Z86.1 Personal history of infectious and parasitic diseases
0.006 0.994 0.000
Y59.3 Immunoglobulin
0.006 0.994 0.000
Y46.8 Antispasticity drugs
0.006 0.994 0.000
Y46.5 Valproic acid
0.006 0.994 0.000
Y46.3 Deoxybarbiturates
0.006 0.994 0.000
Y46.1 Oxazolidinediones
0.006 0.994 0.000
Y46.0 Succinimides
0.006 0.994 0.000
Y54.4 Loop [high-ceiling] diuretics
0.006 0.994 0.000
Y46.4 Iminostilbenes
0.006 0.994 0.000
C17.9 Small intestine, unspecified
0.006 0.994 0.000
C21.1 Anal canal
0.006 0.994 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.006 0.994 0.000
Y46.2 Hydantoin derivatives
0.006 0.994 0.000
C21.2 Cloacogenic zone
0.006 0.994 0.000
Y40.0 Penicillins
0.006 0.994 0.000
Y47.1 Benzodiazepines
0.005 0.994 0.000
Y49.9 Psychotropic drug, unspecified
0.005 0.994 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.005 0.994 0.000
Y49.7 Psychostimulants with abuse potential
0.005 0.994 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.005 0.994 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.005 0.994 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.005 0.994 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.005 0.994 0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]
0.000 0.994 0.006
Y49.5 Other antipsychotics and neuroleptics
0.005 0.994 0.000
Y57.7 Vitamins, not elsewhere classified
0.005 0.995 0.000
Y57.4 Pharmaceutical excipients
0.005 0.995 0.000
Y57.3 Alcohol deterrents
0.005 0.995 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.005 0.995 0.000
Y57.1 Lipotropic drugs
0.005 0.995 0.000
Y57.0 Appetite depressants [anorectics]
0.005 0.995 0.000
S64.2 Injury of radial nerve at wrist and hand level
0.005 0.995 0.000
M25.84 Other specified joint disorders (Hand)
0.000 0.995 0.005
K14.9 Disease of tongue, unspecified
0.000 0.995 0.005
Z89.2 Acquired absence of upper limb above wrist
0.000 0.995 0.005
C21.8 Overlapping lesion of rectum, anus and anal canal
0.005 0.995 0.000
Y46.6 Other and unspecified antiepileptics
0.005 0.995 0.000
C17.1 Jejunum
0.005 0.995 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.005 0.995 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
H33.4 Traction detachment of retina
0.000 0.995 0.005
Y41.0 Sulphonamides
0.005 0.995 0.000
Z89.9 Acquired absence of limb, unspecified
0.000 0.995 0.005
C15.3 Upper third of oesophagus
0.005 0.995 0.000
J44.8 Other specified chronic obstructive pulmonary disease
0.005 0.995 0.000
H33.1 Retinoschisis and retinal cysts
0.000 0.995 0.005
H32 Chorioretinal disorders in diseases classified elsewhere
0.000 0.995 0.005
M77.4 Metatarsalgia
0.000 0.995 0.005
Y48.5 Therapeutic gases
0.005 0.995 0.000
Y48.1 Parenteral anaesthetics
0.005 0.995 0.000
Y48.0 Inhaled anaesthetics
0.005 0.995 0.000
Z89.8 Acquired absence of upper and lower limbs [any level]
0.000 0.995 0.005
Z89.3 Acquired absence of both upper limbs [any level]
0.000 0.995 0.005
Z89.1 Acquired absence of hand and wrist
0.000 0.995 0.005
Y57.8 Other drugs and medicaments
0.005 0.995 0.000
N04.9 Unspecified
0.005 0.995 0.000
N02.9 Unspecified
0.000 0.995 0.005
S62.40 Multiple fractures of metacarpal bones (closed)
0.005 0.995 0.000
H33.5 Other retinal detachments
0.000 0.995 0.005
K14.0 Glossitis
0.000 0.995 0.005
Y48.3 Local anaesthetics
0.005 0.995 0.000
H35.8 Other specified retinal disorders
0.000 0.995 0.005
Y57.6 Other diagnostic agents
0.005 0.995 0.000
Y43 Primarily systemic agents
0.005 0.995 0.000
C15.8 Overlapping lesion of oesophagus
0.005 0.995 0.000
C15.2 Abdominal part of oesophagus
0.005 0.995 0.000
C15.1 Thoracic part of oesophagus
0.005 0.995 0.000
C15.0 Cervical part of oesophagus
0.005 0.995 0.000
K14.5 Plicated tongue
0.000 0.995 0.005
K14.4 Atrophy of tongue papillae
0.000 0.995 0.005
K14.3 Hypertrophy of tongue papillae
0.000 0.995 0.005
K14.2 Median rhomboid glossitis
0.000 0.995 0.005
K14.1 Geographic tongue
0.000 0.995 0.005
Y49.2 Other and unspecified antidepressants
0.005 0.995 0.000
Y48.2 Other and unspecified general anaesthetics
0.004 0.995 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.005 0.995 0.000
H35 Other retinal disorders
0.000 0.995 0.005
H33.3 Retinal breaks without detachment
0.000 0.996 0.004
H35.7 Separation of retinal layers
0.000 0.996 0.004
H31 Other disorders of choroid
0.000 0.996 0.004
C15.4 Middle third of oesophagus
0.004 0.996 0.000
I31.3 Pericardial effusion (noninflammatory)
0.004 0.996 0.000
H30 Chorioretinal inflammation
0.000 0.996 0.004
C15.9 Oesophagus, unspecified
0.004 0.996 0.000
R47.8 Other and unspecified speech disturbances
0.004 0.996 0.000
Y40.9 Systemic antibiotic, unspecified
0.004 0.996 0.000
N71.1 Chronic inflammatory disease of uterus
0.000 0.996 0.004
Z89.0 Acquired absence of finger(s) [including thumb], unilateral
0.000 0.996 0.004
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation
0.004 0.996 0.000
K14.6 Glossodynia
0.000 0.996 0.004
Y43.0 Antiallergic and antiemetic drugs
0.004 0.996 0.000
M25.85 Other specified joint disorders (Pelvic region and thigh)
0.000 0.996 0.004
R93 Abnormal findings on diagnostic imaging of other body structures
0.004 0.996 0.000
N71.9 Inflammatory disease of uterus, unspecified
0.000 0.996 0.004
S64.1 Injury of median nerve at wrist and hand level
0.004 0.996 0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere
0.000 0.996 0.004
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere
0.000 0.996 0.004
M77.49 Metatarsalgia-Site unspec
0.000 0.996 0.004
M77.48 Metatarsalgia-Other
0.000 0.996 0.004
M77.46 Metatarsalgia-Lower Leg
0.000 0.996 0.004
M77.45 Metatarsalgia-Pelvic/Thigh
0.000 0.996 0.004
M77.44 Metatarsalgia-Hand
0.000 0.996 0.004
M77.43 Metatarsalgia-Forearm
0.000 0.996 0.004
M77.42 Metatarsalgia-Upper arm
0.000 0.996 0.004
M77.41 Metatarsalgia-Shldr region
0.000 0.996 0.004
M77.40 Metatarsalgia-Mult sites
0.000 0.996 0.004
L81.4 Other melanin hyperpigmentation
0.000 0.996 0.004
Y43.1 Antineoplastic antimetabolites
0.004 0.996 0.000
C20 Malignant neoplasm of rectum
0.004 0.996 0.000
Y43.9 Primarily systemic agent, unspecified
0.004 0.996 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.004 0.996 0.000
Y43.6 Enzymes, not elsewhere classified
0.004 0.996 0.000
Y43.5 Acidifying and alkalising agents
0.004 0.996 0.000
Y43.2 Antineoplastic natural products
0.004 0.996 0.000
Y48.4 Anaesthetic, unspecified
0.003 0.996 0.000
S64.3 Injury of digital nerve of thumb
0.004 0.996 0.000
C21.0 Anus, unspecified
0.003 0.996 0.000
M25.8 Other specified joint disorders
0.000 0.996 0.004
S64 Injury of nerves at wrist and hand level
0.004 0.996 0.000
M41.96 Scoliosis, unspecified (Lumbar region)
0.004 0.996 0.000
C69.3 Choroid
0.004 0.996 0.000
L40 Psoriasis
0.004 0.996 0.000
H35.9 Retinal disorder, unspecified
0.000 0.996 0.004
N71 Inflammatory disease of uterus, except cervix
0.000 0.996 0.004
H35.1 Retinopathy of prematurity
0.000 0.996 0.003
H31.1 Choroidal degeneration
0.000 0.996 0.003
M65.34 Trigger finger-Hand
0.000 0.996 0.004
H35.4 Peripheral retinal degeneration
0.000 0.996 0.003
Z89.4 Acquired absence of foot and ankle
0.000 0.996 0.003
M94.88 Other specified disorders of cartilage (Other)
0.003 0.997 0.000
H31.9 Disorder of choroid, unspecified
0.000 0.997 0.003
H31.4 Choroidal detachment
0.000 0.997 0.003
H31.3 Choroidal haemorrhage and rupture
0.000 0.997 0.003
H31.2 Hereditary choroidal dystrophy
0.000 0.997 0.003
H31.0 Chorioretinal scars
0.000 0.997 0.003
H30.8 Other chorioretinal inflammations
0.000 0.997 0.003
H30.2 Posterior cyclitis
0.000 0.997 0.003
H30.1 Disseminated chorioretinal inflammation
0.000 0.997 0.003
H30.0 Focal chorioretinal inflammation
0.000 0.997 0.003
M25.88 Other specified joint disorders (Other)
0.000 0.997 0.003
H35.2 Other proliferative retinopathy
0.000 0.997 0.003
I34.1 Mitral (valve) prolapse
0.000 0.997 0.003
H35.6 Retinal haemorrhage
0.000 0.997 0.003
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts
0.000 0.997 0.003
I34.0 Mitral (valve) insufficiency
0.000 0.997 0.003
M94.8 Other specified disorders of cartilage
0.003 0.997 0.000
Z29.8 Other specified prophylactic measures
0.003 0.997 0.000
R93.6 Abnormal findings on diagnostic imaging of limbs
0.003 0.997 0.000
H36 Retinal disorders in diseases classified elsewhere
0.000 0.997 0.003
M25.87 Other specified joint disorders (Ankle and foot)
0.000 0.997 0.003
M94.89 Other specified disorders of cartilage (Site unspecified)
0.003 0.997 0.000
N71.0 Acute inflammatory disease of uterus
0.000 0.997 0.003
R93.0 Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified
0.003 0.997 0.000
L40.1 Generalised pustular psoriasis
0.003 0.997 0.000
L40.0 Psoriasis vulgaris
0.003 0.997 0.000
R93.2 Abnormal findings on diagnostic imaging of liver and biliary tract
0.003 0.997 0.000
M25.89 Other specified joint disorders (Site unspecified)
0.000 0.997 0.003
M25.82 Other specified joint disorders (Upper arm)
0.000 0.997 0.003
M25.80 Other specified joint disorders (Multiple sites)
0.000 0.997 0.003
L40.3 Pustulosis palmaris et plantaris
0.003 0.997 0.000
S64.9 Injury of unspecified nerve at wrist and hand level
0.003 0.997 0.000
S64.8 Injury of other nerves at wrist and hand level
0.003 0.997 0.000
S64.7 Injury of multiple nerves at wrist and hand level
0.003 0.997 0.000
Z97.5 Presence of (intra-uterine) contraceptive device
0.003 0.997 0.000
F31.9 Bipolar affective disorder, unspecified
0.003 0.997 0.000
O86 Other puerperal infections
0.003 0.997 0.000
R59 Enlarged lymph nodes
0.003 0.997 0.000
L40.4 Guttate psoriasis
0.003 0.997 0.000
L40.2 Acrodermatitis continua
0.003 0.997 0.000
O86.4 Pyrexia of unknown origin following delivery
0.003 0.997 0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)
0.003 0.997 0.000
R59.1 Generalised enlarged lymph nodes
0.003 0.997 0.000
F30.0 Hypomania
0.003 0.997 0.000
L40.8 Other psoriasis
0.003 0.997 0.000
Y83.4 Other reconstructive surgery
0.000 0.997 0.003
M25.81 Other specified joint disorders (Shoulder region)
0.000 0.997 0.003
O90.8 Other complications of the puerperium, not elsewhere classified
0.003 0.997 0.000
S64.0 Injury of ulnar nerve at wrist and hand level
0.003 0.997 0.000
N43 Hydrocele and spermatocele
0.003 0.997 0.000
M94.86 Other specified disorders of cartilage (Lower leg)
0.003 0.997 0.000
Z88.6 Personal history of allergy to analgesic agent
0.003 0.997 0.000
O90 Complications of the puerperium, not elsewhere classified
0.003 0.997 0.000
M25.83 Other specified joint disorders (Forearm)
0.000 0.997 0.002
M94.87 Other specified disorders of cartilage (Ankle and foot)
0.002 0.997 0.000
M94.84 Other specified disorders of cartilage (Hand)
0.002 0.997 0.000
M94.83 Other specified disorders of cartilage (Forearm)
0.002 0.997 0.000
M94.82 Other specified disorders of cartilage (Upper arm)
0.002 0.997 0.000
M94.81 Other specified disorders of cartilage (Shoulder region)
0.002 0.997 0.000
M94.80 Other specified disorders of cartilage (Multiple sites)
0.002 0.997 0.000
R93.7 Abnormal findings on diagnostic imaging of other parts of musculoskeletal system
0.003 0.997 0.000
Y57.9 Drug or medicament, unspecified
0.002 0.997 0.000
H30.9 Chorioretinal inflammation, unspecified
0.001 0.997 0.002
H35.5 Hereditary retinal dystrophy
0.000 0.997 0.002
R93.5 Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
0.003 0.997 0.000
O86.2 Urinary tract infection following delivery
0.002 0.997 0.000
O86.0 Infection of obstetric surgical wound
0.003 0.997 0.000
N04 Nephrotic syndrome
0.003 0.997 0.000
H36.8 Other retinal disorders in diseases classified elsewhere
0.000 0.997 0.002
M82.10 Osteoporosis in endocrine disorders (Multiple sites)
0.003 0.997 0.000
F30.9 Manic episode, unspecified
0.002 0.997 0.000
O85-O92 Complications predominantly related to the puerperium
0.003 0.997 0.000
R47 Speech disturbances, not elsewhere classified
0.002 0.998 0.000
H33.2 Serous retinal detachment
0.000 0.998 0.002
O90.2 Haematoma of obstetric wound
0.002 0.998 0.000
F30 Manic episode
0.002 0.998 0.000
T79.3 Post-traumatic wound infection, not elsewhere classified
0.002 0.998 0.000
I34 Nonrheumatic mitral valve disorders
0.000 0.998 0.002
H31.8 Other specified disorders of choroid
0.001 0.998 0.002
O86.1 Other infection of genital tract following delivery
0.002 0.998 0.000
F39 Unspecified mood [affective] disorder
0.002 0.998 0.000
Y43.4 Immunosuppressive agents
0.002 0.998 0.000
O86.8 Other specified puerperal infections
0.002 0.998 0.000
O86.3 Other genito-urinary tract infections following delivery
0.002 0.998 0.000
F34.1 Dysthymia
0.002 0.998 0.000
I35.0 Aortic (valve) stenosis
0.002 0.998 0.000
O89 Complications of anaesthesia during the puerperium
0.002 0.998 0.000
S62.4 Multiple fractures of metacarpal bones
0.002 0.998 0.000
C15.5 Lower third of oesophagus
0.002 0.998 0.000
D03.3 Melanoma in situ of other and unspecified parts of face
0.002 0.998 0.000
S51.8 Open wound of other parts of forearm
0.002 0.998 0.000
O92 Other disorders of breast and lactation associated with childbirth
0.002 0.998 0.000
O85 Puerperal sepsis
0.002 0.998 0.000
F31.0 Bipolar affective disorder, current episode hypomanic
0.002 0.998 0.000
J33.9 Nasal polyp, unspecified
0.002 0.998 0.000
N43.2 Other hydrocele
0.002 0.998 0.000
N43.1 Infected hydrocele
0.002 0.998 0.000
N43.0 Encysted hydrocele
0.002 0.998 0.000
R47.1 Dysarthria and anarthria
0.002 0.998 0.000
N04.1 Focal and segmental glomerular lesions
0.002 0.998 0.000
O89.4 Spinal and epidural anaesthesia-induced headache during the puerperium
0.002 0.998 0.000
O90.5 Postpartum thyroiditis
0.002 0.998 0.000
O90.4 Postpartum acute renal failure
0.002 0.998 0.000
O90.3 Cardiomyopathy in the puerperium
0.002 0.998 0.000
O90.0 Disruption of Caesarean section wound
0.002 0.998 0.000
O92.2 Other and unspecified disorders of breast associated with childbirth
0.002 0.998 0.000
M94 Other disorders of cartilage
0.002 0.998 0.000
O72.2 Delayed and secondary postpartum haemorrhage
0.002 0.998 0.000
K50 Crohn's disease [regional enteritis]
0.000 0.998 0.002
L81 Other disorders of pigmentation
0.000 0.998 0.002
M94.96 Disorder of cartilage, unspecified (Lower leg)
0.002 0.998 0.000
Z48.8 Other specified surgical follow-up care
0.000 0.998 0.002
C25 Malignant neoplasm of pancreas
0.002 0.998 0.000
M94.9 Disorder of cartilage, unspecified
0.002 0.998 0.000
N04.8 Other
0.002 0.998 0.000
N04.7 Diffuse crescentic glomerulonephritis
0.002 0.998 0.000
N04.6 Dense deposit disease
0.002 0.998 0.000
N04.5 Diffuse mesangiocapillary glomerulonephritis
0.002 0.998 0.000
N04.4 Diffuse endocapillary proliferative glomerulonephritis
0.002 0.998 0.000
N04.3 Diffuse mesangial proliferative glomerulonephritis
0.002 0.998 0.000
N04.2 Diffuse membranous glomerulonephritis
0.002 0.998 0.000
F31 Bipolar affective disorder
0.002 0.998 0.000
D48.5 Skin
0.002 0.998 0.000
I84.3 External thrombosed haemorrhoids
0.002 0.998 0.000
N04.0 Minor glomerular abnormality
0.002 0.998 0.000
O90.1 Disruption of perineal obstetric wound
0.002 0.998 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.